Label Changes for:

Alli (orlistat) capsules

September 2010

Changes have been made to the WARNINGS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010



Stop use and ask a doctor if:
  • you develop itching
  • yellow eyes or skin
  • dark urine or loss of appetite
  • There have been rare reports of liver injury in people taking orlistat